We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+14.55%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$48.4B
AUM Growth
+$6.98B
Cap. Flow
+$2.25B
Cap. Flow %
4.65%
Top 10 Hldgs %
32.53%
Holding
907
New
61
Increased
512
Reduced
260
Closed
23

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$156M
2
AAPL icon
Apple
AAPL
+$146M
3
NVDA icon
NVIDIA
NVDA
+$116M
4
AMZN icon
Amazon
AMZN
+$112M
5
META icon
Meta Platforms (Facebook)
META
+$102M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$112M
2
CRH icon
CRH
CRH
+$63M
3
BAH icon
Booz Allen Hamilton
BAH
+$53.1M
4
ADSK icon
Autodesk
ADSK
+$49.6M
5
AJG icon
Arthur J. Gallagher & Co
AJG
+$46.5M

Sector Composition

Rank Sector Weight
1 Technology 33.06%
2 Financials 14.46%
3 Consumer Discretionary 10.73%
4 Communication Services 9.55%
5 Healthcare 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LPX icon
801
Louisiana-Pacific
LPX
$5.17B
$447K ﹤0.01%
5,198
-1,325
-20% -$118K
TK icon
802
Teekay
TK
$967M
$446K ﹤0.01%
54,038
-38,694
-42% -$300K
RIGL icon
803
Rigel Pharmaceuticals
RIGL
$675M
$446K ﹤0.01%
23,789
+3,285
+16% +$62.3K
MDXG icon
804
MiMedx Group
MDXG
$627M
$445K ﹤0.01%
72,812
-4,348
-6% -$28.9K
CSW
805
CSW Industrials
CSW
$4.81B
$445K ﹤0.01%
1,550
-507
-25% -$153K
TGLS icon
806
Tecnoglass
TGLS
$2.01B
$444K ﹤0.01%
5,738
-3,138
-35% -$243K
CRVL icon
807
CorVel
CRVL
$3.05B
$443K ﹤0.01%
4,310
-1,403
-25% -$155K
HLNE icon
808
Hamilton Lane
HLNE
$3.69B
$442K ﹤0.01%
3,109
-1,018
-25% -$153K
INSP icon
809
Inspire Medical Systems
INSP
$1.46B
$441K ﹤0.01%
3,396
-35
-1% -$5.08K
SWKS icon
810
Skyworks Solutions
SWKS
$9.1B
$440K ﹤0.01%
5,909
-37
-0.6% -$2.47K
STNG icon
811
Scorpio Tankers
STNG
$3.93B
$440K ﹤0.01%
11,245
-4,053
-26% -$158K
ADMA icon
812
ADMA Biologics
ADMA
$1.91B
$439K ﹤0.01%
24,121
-11,385
-32% -$232K
WDFC icon
813
WD-40
WDFC
$3.12B
$439K ﹤0.01%
1,923
-661
-26% -$156K
NXT icon
814
Nextpower Inc
NXT
$15.3B
$439K ﹤0.01%
8,067
-5,731
-42% -$287K
YELP icon
815
Yelp
YELP
$1.4B
$439K ﹤0.01%
12,797
-4,332
-25% -$157K
DHT icon
816
DHT Holdings
DHT
$2.96B
$434K ﹤0.01%
40,116
-17,652
-31% -$195K
TNK icon
817
Teekay Tankers
TNK
$2.61B
$433K ﹤0.01%
10,368
-5,405
-34% -$231K
HRMY icon
818
Harmony Biosciences
HRMY
$2.05B
$432K ﹤0.01%
13,659
-4,221
-24% -$136K
UPWK icon
819
Upwork
UPWK
$1.1B
$425K ﹤0.01%
31,638
-11,276
-26% -$162K
CPRX
820
DELISTED
Catalyst Pharmaceutical
CPRX
$425K ﹤0.01%
19,568
-7,868
-29% -$186K
AEE icon
821
Ameren
AEE
$31.4B
$424K ﹤0.01%
4,418
SKY icon
822
Champion Homes
SKY
$4.51B
$423K ﹤0.01%
6,750
+469
+7% +$36.5K
PPL
823
PPL Corp
PPL
$27.3B
$422K ﹤0.01%
12,461
WINA icon
824
Winmark
WINA
$1.21B
$413K ﹤0.01%
1,093
-798
-42% -$308K
AMG icon
825
Affiliated Managers Group
AMG
$9.38B
$410K ﹤0.01%
+2,085
New +$362K

Similar funds

Aviva's Q2 2025 Portfolio in Review

As of Q2 2025, Aviva held 907 positions worth $48.4B, up 17% from $41.4B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Aviva deployed $2.25B of net new capital in Q2 2025, opening 61 new positions and adding to 512 existing holdings. Its largest new stake was Tapestry: 769,981 shares worth $67.6M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $112M trimmed.

  • Aviva's largest Q2 2025 buy was Tapestry: 769,981 shares worth $67.6M.
  • Aviva added most to Microsoft in Q2 2025, an estimated $156M increase.
  • Aviva's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $112M.
  • Aviva fully exited Discover Financial Services in Q2 2025, selling an estimated $41.6M.
  • Aviva's ten largest holdings make up 33% of its $48.4B portfolio in Q2 2025.
  • Aviva opened 61 new positions and closed 23 in Q2 2025.
  • Aviva's portfolio value rose 17% quarter-over-quarter to $48.4B.

Based on Aviva's 13F filing for Q2 2025, filed 7 Aug 2025.